InterK Peptide Therapeutics is a preclinical biotechnology company that has developed small, non-naturally occurring peptides that modulate the immune system.

These compounds have potential benefit against autoimmune diseases, as complementary treatment together with cancer immunotherapy, as an adjuvant in anti-viral vaccination strategies, and in repairing ultraviolet radiation-induced skin damage.



Contact Us
Email mail@interk.com.au